Paper Details

  1. Home
  2. Paper Details

Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China.

Author: FuYanhua, GanLin, LiJun, LongHai, SongChunli, SongYebing, XieXiaoxin, YangXiaoyan

Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A real-world study in Southwestern China found that the combination of dolutegravir plus lamivudine (DTG+3TC) was effective and safe for long-term treatment of HIV infection.
Paper Details　
Original Abstract of the Article :
Long-term outcome data from real-world studies on the implementation of a two-drug dolutegravir plus lamivudine (DTG+3TC) regimen for the treatment of human immunodeficiency virus (HIV) infection remain limited. This study evaluated the real-world effectiveness and safety of DTG+3TC in people living...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14787210.2022.2128766

データ提供：米国国立医学図書館（NLM）

Dolutegravir Plus Lamivudine: A New Oasis in the Desert of HIV Treatment

HIV infection remains a significant global health concern, requiring effective and accessible treatment. This study evaluates the effectiveness and safety of a two-drug regimen, dolutegravir plus lamivudine (DTG+3TC), in people living with HIV (PLHIV) in Southwestern China.

Navigating the Desert of HIV

The study found that DTG+3TC was effective and safe in a real-world setting, providing a promising treatment option for PLHIV in Southwestern China. This is like finding a new oasis in the desert of HIV, offering a potentially effective and safe route to manage the disease.

A Path Toward Better Management

The study suggests that DTG+3TC could potentially improve access to HIV treatment, offering a more manageable approach to managing the disease. This is like discovering a new path through the desert, leading to better outcomes and a potentially brighter future for individuals living with HIV.

Dr. Camel's Conclusion

This study provides encouraging news for individuals living with HIV, highlighting the potential of DTG+3TC to improve treatment access and outcomes. This research represents a step forward in the journey towards better management of HIV, offering a glimmer of hope in the desert of disease.
Date :
  1. Date Completed 2022-10-25
  2. Date Revised 2022-12-14
Further Info :

Pubmed ID

36168914

DOI: Digital Object Identifier

10.1080/14787210.2022.2128766

Related Literature

Article Analysis
・Side Effects of lamivudine・Side Effects of 3tc
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.